Published within
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Analysis of healthcare expenditure, reforms, pricing and reimbursement and drug regulation across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.
Published By Datamonitor
|
25 Mar 2011 |
$3800
|
Report
|
An analysis of global sales forecasts for the top 50 companies during 2010–15.
Published By Datamonitor
|
28 Feb 2011 |
$1900
|
Report
|
Comparative analysis of biosimilar drivers and resistors, key players, market access, pricing, and future launches across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.
Published By Datamonitor
|
23 Feb 2011 |
$3800
|
Report
|
Overview of the Indian pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
21 Dec 2010 |
$7600
|
Report
|
An overview of licensing and alliance trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q3 2009 to Q2 2010, including discussion of the drivers of recent deals and analysis of key agreements.
Published By Datamonitor
|
19 Nov 2010 |
$7600
|
Report
|
An overview of merger and acquisition (M&A) trends in developed and emerging pharmaceutical markets in the Asia-Pacific region from Q1 2007 to Q1 2010, with discussion of the drivers of recent deals and analysis of key M&As in individual countries.
Published By Datamonitor
|
19 Aug 2010 |
$7600
|
Report
|
This report analyzes three emerging markets, Brazil, Russia and India as targets for HIV drug manufacturers. It discusses the commercial and regulatory environment, guidelines, domestic and multinational competition as well as market entry strategies.
Published By Datamonitor
|
25 May 2010 |
$3800
|
Report
|
An overview of key trends shaping the pharmaceutical industry today, as well as drivers and resistors that are set to play a central role in the future as companies look to increase sales and boost profitability.
Published By Datamonitor
|
17 Mar 2010 |
$11400
|
Report
|
An overview of M&A trends for the top 150 global pharmaceutical companies during 2008 and 2009 with discussion of the drivers of recent deals, plus case study analysis of key M&As.
Published By Datamonitor
|
17 Dec 2009 |
$11400
|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.